Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
2021 · Radiation Oncology · 10 citations
https://doi.org/10.1186/s13014-021-01872-9
M
Miriam Eckl
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
113
Citations
5
h-index
3
i10-index
Miriam Eckl is an academic researcher from Heidelberg University. The author has contributed to research in topics: Advanced Radiotherapy Techniques & Medical Imaging Techniques and Applications & Radiomics and Machine Learning in Medical Imaging. The author has an h-index of 5, co-authored 19 publications.
ORCID: 0000-0002-8748-9704Papers by this author
worksLongitudinal stability of HyperSightTM-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancer
2025 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-025-99920-x
Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma – a multicenter cohort analysis
2025 · Journal of bone oncology · 1 citations
https://doi.org/10.1016/j.jbo.2025.100710
321: Semi-automated reproducible target transfer for STAR – Cross-validation within the RAVENTA trial
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)00976-9
PP26.11 RADIOMICS FEATURE STABILITY IN ORGANIC PHANTOMS FOR NOVEL CBCT IMAGING
2024 · Physica Medica · 0 citations
https://doi.org/10.1016/j.ejmp.2024.103933
1924 The impact of adaptation time on treatment quality in CBCT-based ultra-hypofractionated adaptive radiation therapy for prostate cancer
2025 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(25)00738-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat